Apotex announces Jeff Watson as new CEO after Allan Oberman steps down
Advertisement
Read this article for free:
or
Already have an account? Log in here »
To continue reading, please subscribe:
Monthly Digital Subscription
$1 per week for 24 weeks*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*Billed as $4.00 plus GST every four weeks. After 24 weeks, price increases to the regular rate of $19.95 plus GST every four weeks. Offer available to new and qualified returning subscribers only. Cancel any time.
Monthly Digital Subscription
$4.99/week*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*Billed as $19.95 plus GST every four weeks. Cancel any time.
To continue reading, please subscribe:
Add Free Press access to your Brandon Sun subscription for only an additional
$1 for the first 4 weeks*
*Your next subscription payment will increase by $1.00 and you will be charged $16.99 plus GST for four weeks. After four weeks, your payment will increase to $23.99 plus GST every four weeks.
Read unlimited articles for free today:
or
Already have an account? Log in here »
TORONTO – Apotex Inc. announced its CEO, Allan Oberman, is stepping down effective immediately.
The Toronto-based drug company says he will be succeeded by Jeff Watson, who previously served as the CEO from 2018 to 2023.
Aaron Davenport, the chairman of Apotex’s board, says Watson’s track record of delivering results and his commitment to patient access and innovation make him an ideal leader for the company.
He also says Oberman’s industry expertise and leadership have been instrumental in shaping the strategic direction of the company.
Apotex says Oberman, who has acted as president and CEO since 2023, will resume his role as a member of the board as part of the transition.
The leadership change comes after Apotex moved in February to acquire CanPrev, a Canadian provider of vitamins, supplements and other natural health products.
This report by The Canadian Press was first published March 30, 2026.